Form 4: Astronics Director Keane Reports Stock Sales and RSU Holdings

Director Robert S. Keane reports sales of Astronics Corp stock and holdings of common stock and restricted stock units.

Summary

• Robert S. Keane, a director of Astronics Corp, filed a Form 4 detailing changes in beneficial ownership.
• On March 7, 2025, Keane sold 26,041 shares of common stock at $24.55 per share and 51,058 shares of common stock at $24.55 per share.
• Following these transactions, Keane directly owns 6,346 shares of common stock.
• Keane also indirectly owns shares through trusts: EAK & KRK Trust U/A/D 10-15-97 FBO Elizabeth A. Keane (37,700 common stock shares and 206,886 Class B stock shares) and Boston & Saranac LLC (51,058 common stock shares and 408,199 Class B stock shares).
• Keane also holds 6,055 restricted stock units (RSUs) that vest on August 27, 2025, each representing one share of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document indicates the vesting schedule for the restricted stock units, which vest 100% on August 27, 2025.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• Shareholders may interpret the stock sales as a signal, although further analysis would be needed to understand the motivations behind the transactions.
• The vesting of restricted stock units could impact the company's share dilution.

Key Dates